Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Soma

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Anticancer Research|January 1, 1997
Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamideH Inagawa, S Ohshiro, T Nishizawa, et al.
Journal of Biological Response Modifiers|October 1, 1987
Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial originM Satoh, H Inagawa, Y Shimada, et al.
Biochemistry International|March 1, 1989
Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factorY Tsuji, N Kitahara-Tanabe, K Noguchi, et al.
Fish & Shellfish Immunology|June 8, 2001
Tumor necrosis factor alpha (TNFalpha)-like factor produced by macrophages in rainbow trout, Oncorhynchus mykissQ W Qin, M Ototake, K Noguchi, et al.
The EMBO Journal|September 1, 1985
Tissue-specific regulation of a chicken delta-crystallin gene in mouse cells: involvement of the 5' end regionS Hayashi, H Kondoh, K Yasuda, et al.
Anticancer Research|December 29, 2000
Clinical significance of the expression of endothelial-monocyte activating polypeptide II (EMAPII) in the treatment of glioblastoma with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2)M Yamamoto, T Fukushima, Y Ueno, et al.
European Cytokine Network|July 1, 1992
Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomeransT Okutomi, T Nishizawa, H Inagawa, et al.
Molecular Biotherapy|December 1, 1991
Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiersT Nishizawa, T Okutomi, H Inagawa, et al.
Life Sciences|January 1, 1994
Effects of a lipopolysaccharide from Pantoea agglomerans on the cocaine-induced place preferenceT Suzuki, M Funada, Y Sugano, et al.
FEMS Microbiology Letters|April 15, 1997
Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharideD Tsukioka, T Nishizawa, T Miyase, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Anticancer Research|January 1, 1997
Augmentation of antitumor effect of endogenously induced tumor necrosis factor by cyclophosphamideH Inagawa, S Ohshiro, T Nishizawa, et al.
Journal of Biological Response Modifiers|October 1, 1987
Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial originM Satoh, H Inagawa, Y Shimada, et al.
Biochemistry International|March 1, 1989
Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factorY Tsuji, N Kitahara-Tanabe, K Noguchi, et al.
Fish & Shellfish Immunology|June 8, 2001
Tumor necrosis factor alpha (TNFalpha)-like factor produced by macrophages in rainbow trout, Oncorhynchus mykissQ W Qin, M Ototake, K Noguchi, et al.
The EMBO Journal|September 1, 1985
Tissue-specific regulation of a chicken delta-crystallin gene in mouse cells: involvement of the 5' end regionS Hayashi, H Kondoh, K Yasuda, et al.
Anticancer Research|December 29, 2000
Clinical significance of the expression of endothelial-monocyte activating polypeptide II (EMAPII) in the treatment of glioblastoma with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2)M Yamamoto, T Fukushima, Y Ueno, et al.
European Cytokine Network|July 1, 1992
Inhibition of morphine dependence by a lipopolysaccharide from Pantoea agglomeransT Okutomi, T Nishizawa, H Inagawa, et al.
Molecular Biotherapy|December 1, 1991
Intratumoral tumor necrosis factor induction in tumor-bearing mice by exogenous/endogenous tumor necrosis factor therapy as compared with systemic administration of various biologic response modifiersT Nishizawa, T Okutomi, H Inagawa, et al.
Life Sciences|January 1, 1994
Effects of a lipopolysaccharide from Pantoea agglomerans on the cocaine-induced place preferenceT Suzuki, M Funada, Y Sugano, et al.
FEMS Microbiology Letters|April 15, 1997
Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharideD Tsukioka, T Nishizawa, T Miyase, et al.
Pageof 9